Literature DB >> 23401856

C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophy.

Ara Koh1, Mi Nam Lee, Yong Ryoul Yang, Heeyoon Jeong, Jaewang Ghim, Jeongeun Noh, Jaeyoon Kim, Dongryeol Ryu, Sehoon Park, Parkyong Song, Seung-Hoi Koo, Nick R Leslie, Per-Olof Berggren, Jang Hyun Choi, Pann-Ghill Suh, Sung Ho Ryu.   

Abstract

Muscle atrophy occurs under various catabolic conditions, including insulin deficiency, insulin resistance, or increased levels of glucocorticoids. This results from reduced levels of insulin receptor substrate 1 (IRS-1), leading to decreased phosphatidylinositol 3-kinase activity and thereby activation of FoxO transcription factors. However, the precise mechanism of reduced IRS-1 under a catabolic condition is unknown. Here, we report that C1-Ten is a novel protein tyrosine phosphatase (PTPase) of IRS-1 that acts as a mediator to reduce IRS-1 under a catabolic condition, resulting in muscle atrophy. C1-Ten preferentially dephosphorylated Y612 of IRS-1, which accelerated IRS-1 degradation. These findings suggest a novel type of IRS-1 degradation mechanism which is dependent on C1-Ten and extends our understanding of the molecular mechanism of muscle atrophy under catabolic conditions. C1-Ten expression is increased by catabolic glucocorticoid and decreased by anabolic insulin. Reflecting these hormonal regulations, the muscle C1-Ten is upregulated in atrophy but downregulated in hypertrophy. This reveals a previously unidentified role of C1-Ten as a relevant PTPase contributing to skeletal muscle atrophy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23401856      PMCID: PMC3624259          DOI: 10.1128/MCB.01447-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling.

Authors:  Taiyi Kuo; Michelle J Lew; Oleg Mayba; Charles A Harris; Terence P Speed; Jen-Chywan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

2.  Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.

Authors:  Sassan Hafizi; Anna Gustafsson; Cecilia Oslakovic; Olof Idevall-Hagren; Anders Tengholm; Olivier Sperandio; Bruno O Villoutreix; Björn Dahlbäck
Journal:  Biochem Biophys Res Commun       Date:  2010-08-03       Impact factor: 3.575

3.  The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling.

Authors:  Jun Shi; Liqing Luo; John Eash; Chikwendu Ibebunjo; David J Glass
Journal:  Dev Cell       Date:  2011-10-25       Impact factor: 12.270

4.  Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways.

Authors:  Yun Chau Long; Zhiyong Cheng; Kyle D Copps; Morris F White
Journal:  Mol Cell Biol       Date:  2010-12-06       Impact factor: 4.272

Review 5.  11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus.

Authors:  G Hollis; R Huber
Journal:  Diabetes Obes Metab       Date:  2011-01       Impact factor: 6.577

6.  Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

Authors:  F Giorgino; A Almahfouz; L J Goodyear; R J Smith
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.

Authors:  F Giorgino; R J Smith
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II.

Authors:  J R Florini; K A Magri; D Z Ewton; P L James; K Grindstaff; P S Rotwein
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice.

Authors:  M J Orland; M A Permutt
Journal:  Diabetes       Date:  1987-03       Impact factor: 9.461

10.  Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency.

Authors:  Dawn E W Livingstone; Sarah L Grassick; Gillian L Currie; Brian R Walker; Ruth Andrew
Journal:  J Endocrinol       Date:  2009-02-17       Impact factor: 4.286

View more
  15 in total

1.  Cellular phosphatase activity of C1-Ten/Tensin2 is controlled by Phosphatidylinositol-3,4,5-triphosphate binding through the C1-Ten/Tensin2 SH2 domain.

Authors:  Eui Kim; Do-Hyeon Kim; Indira Singaram; Heeyoon Jeong; Ara Koh; Jiyoun Lee; Wonhwa Cho; Sung Ho Ryu
Journal:  Cell Signal       Date:  2018-08-07       Impact factor: 4.315

Review 2.  The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins.

Authors:  Fumihiko Hakuno; Toshiaki Fukushima; Yosuke Yoneyama; Hiroyasu Kamei; Atsufumi Ozoe; Hidehito Yoshihara; Daisuke Yamanaka; Takashi Shibano; Meri Sone-Yonezawa; Bu-Chin Yu; Kazuhiro Chida; Shin-Ichiro Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-26       Impact factor: 5.555

3.  Mouse chromosome 2 harbors genetic determinants of resistance to podocyte injury and renal tubulointerstitial fibrosis.

Authors:  Hayato Sasaki; Junpei Kimura; Ken-Ichi Nagasaki; Kiyoma Marusugi; Takashi Agui; Nobuya Sasaki
Journal:  BMC Genet       Date:  2016-05-26       Impact factor: 2.797

4.  iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53.

Authors:  Harumasa Nakazawa; Kyungho Chang; Shohei Shinozaki; Takashi Yasukawa; Kazuhiro Ishimaru; Shingo Yasuhara; Yong-Ming Yu; J A Jeevendra Martyn; Ronald G Tompkins; Kentaro Shimokado; Masao Kaneki
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

5.  Inhibition of C1-Ten PTPase activity reduces insulin resistance through IRS-1 and AMPK pathways.

Authors:  Heeyoon Jeong; Ara Koh; Jiyoun Lee; Dohyun Park; Jung Ok Lee; Mi Nam Lee; Kyung-Jin Jo; Huynh Nguyen Khanh Tran; Eui Kim; Byung-Sun Min; Hyeon Soo Kim; Per-Olof Berggren; Sung Ho Ryu
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

6.  miR-628 Promotes Burn-Induced Skeletal Muscle Atrophy via Targeting IRS1.

Authors:  Yonghui Yu; Xiao Li; Lingying Liu; Jiake Chai; Zhang Haijun; Wanli Chu; Huinan Yin; Li Ma; Hongjie Duan; Mengjing Xiao
Journal:  Int J Biol Sci       Date:  2016-09-15       Impact factor: 6.580

Review 7.  Novel Roles of SH2 and SH3 Domains in Lipid Binding.

Authors:  Szabolcs Sipeki; Kitti Koprivanacz; Tamás Takács; Anita Kurilla; Loretta László; Virag Vas; László Buday
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600

Review 8.  The Roles of Pseudophosphatases in Disease.

Authors:  Andrew M Mattei; Jonathan D Smailys; Emma Marie Wilber Hepworth; Shantá D Hinton
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923

9.  Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers.

Authors:  Shiao-Ya Hong; Yi-Ping Shih; Peng Sun; Wang-Ju Hsieh; Wen-Chang Lin; Su Hao Lo
Journal:  Oncotarget       Date:  2016-06-21

10.  Wushenziye Formula Improves Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus via PTP1B-IRS1-Akt-GLUT4 Signaling Pathway.

Authors:  Chunyu Tian; Hong Chang; Xiaojin La; Ji-An Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.